1. Expression of 14-3-3γ in patients with breast cancer: correlation with clinicopathological features and prognosis
- Author
-
Yunhong Yao, Yulan Song, Zunfu Ke, Chao Zeng, Zheng Yang, Yanqin Sun, Hongmei Li, Xinrong Hu, and Jinbao Yin
- Subjects
CA15-3 ,Oncology ,Adult ,Cancer Research ,medicine.medical_specialty ,Epidemiology ,Mammary gland ,CA 15-3 ,Breast Neoplasms ,Breast cancer ,Internal medicine ,medicine ,Biomarkers, Tumor ,Humans ,Survival rate ,Aged ,business.industry ,Cancer ,Middle Aged ,medicine.disease ,Prognosis ,Immunohistochemistry ,Survival Rate ,medicine.anatomical_structure ,14-3-3 Proteins ,Tumor progression ,Disease Progression ,Female ,business - Abstract
Protein 14-3-3γ is an important member of the 14-3-3 family that play important roles in the regulation of various cellular processes. The aim of the study is to investigate the association between 14-3-3γ expression and the clinicopathological features of patients with breast cancer.The expression of 14-3-3γ was detected by Western blot in both foci of breast cancer and adjacent non-cancerous tissues. In addition, 14-3-3γ expression was analyzed by immunohistochemistry in 60 clinicopathologically characterized breast cancer cases. The association of 14-3-3γ expression with survival of the patients were analyzed.The expression level of 14-3-3γ protein in breast cancer were significantly higher than that in non-cancerous mammary gland tissues. Moreover, high expression of 14-3-3γ correlated with tumor size and tumor grade (all P0.05). Patients with high 14-3-3γ expression had worse overall survival rate than that with low expression (P0.05). Furthermore, multivariate analysis showed that 14-3-3γ expression was an independent predictor of overall survival (HR, 0.196; 95%CI, 0.043-0.892; P = 0.035).Our data suggest for the first time that the increased expression of 14-3-3γ in breast cancer is associated significantly with tumor progression and poor prognosis. 14-3-3γ may be a novel and potential prognostic marker for breast cancer.
- Published
- 2012